Cellular and Molecular Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Department of Cardiology, Urmia University of Medical Sciences, Urmia, Iran.
Clin Exp Med. 2023 Dec;23(8):4457-4472. doi: 10.1007/s10238-023-01179-x. Epub 2023 Sep 11.
In spite of its high mortality rate and difficulty in finding a cure, scientific advancements have contributed to a reduction in cancer-related fatalities. Aberrant gene expression during carcinogenesis emphasizes the importance of targeting the signaling networks that control gene expression in cancer treatment. Long noncoding RNAs (lncRNAs), which are transcribed RNA molecules that play a role in gene expression regulation, are a recent innovative therapeutic approach for diagnosing and treating malignancies. MALAT1, a well-known lncRNA, functions in gene expression, RNA processing, and epigenetic control. High expression levels of MALAT1 are associated with several human disorders, including metastasis, invasion, autophagy, and proliferation of cancer cells. MALAT1 affects various signaling pathways and microRNAs (miRNAs), and this study aims to outline its functional roles in cancer metastasis and its interactions with cellular signaling pathways. Moreover, MALAT1 and its interactions with signaling pathways can be promising target for cancer treatment.
尽管癌症的死亡率很高,且难以治愈,但科学的进步有助于降低癌症相关的死亡率。在致癌过程中基因表达的异常强调了在癌症治疗中靶向控制基因表达的信号网络的重要性。长链非编码 RNA(lncRNA)是一种转录 RNA 分子,在基因表达调控中发挥作用,是诊断和治疗恶性肿瘤的一种新的创新治疗方法。MALAT1 是一种众所周知的 lncRNA,在基因表达、RNA 处理和表观遗传控制中发挥作用。MALAT1 的高表达水平与多种人类疾病有关,包括癌细胞的转移、侵袭、自噬和增殖。MALAT1 影响多种信号通路和 microRNAs(miRNAs),本研究旨在概述其在癌症转移中的功能作用及其与细胞信号通路的相互作用。此外,MALAT1 及其与信号通路的相互作用可能是癌症治疗的有前途的靶点。